How many insider trades does FilingIQ track for TECX?

FilingIQ tracks 88 Form 4 insider transactions for TECX (Tectonic Therapeutic, Inc.), covering filings from Jun 20, 2024 onwards. 22 of those were filed in the last 90 days.

Are TECX insiders net buyers or net sellers?

Across the full Form 4 history for TECX, 21 transactions (24%) were open-market purchases and 8 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TECX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TECX in?

Tectonic Therapeutic, Inc. (TECX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $399.59M.

TECX insider trading

Healthcare

Tectonic Therapeutic, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

24% / 9%

Market cap

$399.59M

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Company website: tectonictx.com

TECX insider activity at a glance

FilingIQ has scored 88 insider transactions for TECX since Jun 20, 2024. The most recent filing in our index is dated May 4, 2026.

Across the full history, 21 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TECX insider trades is 60.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TECX trades on FilingIQ Raw filings on SEC EDGAR

Latest TECX Form 4 filings

SPRINGER TIMOTHY A

P Apr 7, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TECX?: FilingIQ tracks 88 Form 4 insider transactions for TECX (Tectonic Therapeutic, Inc.), covering filings from Jun 20, 2024 onwards. 22 of those were filed in the last 90 days.
Are TECX insiders net buyers or net sellers?: Across the full Form 4 history for TECX, 21 transactions (24%) were open-market purchases and 8 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TECX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TECX in?: Tectonic Therapeutic, Inc. (TECX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $399.59M.

Methodology & sources

Every TECX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.